The Huntington Group currently stands out with a major embryology laboratory in Latin America. Its sophisticated structure in equipment and the numerous investments in technology ensure cutting edge treatments to our patients, while providing maximum comfort and stability to men and women who seek us with the desire to achieve a pregnancy.
Modern techniques and high precision, such as Oocyte Vitrification and pre-implantation genetic diagnosis with biopsy of blastocyst (embryo on day 5 of life) through the technique for Comparative Genomics Hybridization array (CGH-array), were first brought to Brazil by our specialized professionals. The excellence and quality of our services is a reflection of the effort and level of preparedness of our team, formed by a high range of professionals where more than 60% have master’s degrees and doctorates, and are continually seeking improvement with new research and technological strategies.
Our indicators are similar to figures published in renowned sources worldwide in the field of reproductive medicine, such as REDLARA, American Societies (ASRM), European (ESHRE) and Brazilian (SBRA) for Assisted Human Reproduction. Statistical numbers collected by the group in recent years show more than 2000 cycles and show annual rates that exceed 40% of the total births in women who underwent treatment in the clinics of the Huntington Group, through different IVF (In Vitro Fertilization) techniques.
The data is obtained by summing the continuous work and clinical experience and laboratory investigation of all our professionals, doctors, embryologists, nurses and scientists who are fully dedicated to our patients.
Through efficient quality control, established by protocols and signed daily routines since the construction of our first lab, we guarantee the same quality of assisted reproduction procedures in all Group units, providing the best facilities and infrastructure.
The professionals at Huntington conduct a series of research activities and investigation that serve as the basis for our improvement. Linked to educational institutions such as national and international universities, we undertake projects of master’s and doctoral theses, as well as postdoctoral and research works to increasingly improve pregnancy rates annually. We also participate every year in a series of international congresses of paramount importance in the field of reproductive medicine, presenting the preliminary results of these studies.